These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17368959)

  • 21. IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis.
    Lee S; Zheng M; Deshpande S; Eo SK; Hamilton TA; Rouse BT
    J Leukoc Biol; 2002 Mar; 71(3):469-76. PubMed ID: 11867684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.
    Banerjee K; Biswas PS; Kim B; Lee S; Rouse BT
    J Immunol; 2004 Jan; 172(2):1237-45. PubMed ID: 14707102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of stromal keratitis by inhibition of neovascularization.
    Zheng M; Schwarz MA; Lee S; Kumaraguru U; Rouse BT
    Am J Pathol; 2001 Sep; 159(3):1021-9. PubMed ID: 11549594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who (what) pays toll for the development of herpetic stromal keratitis (HSK).
    Hayashi K; Hooper LC; Hooks JJ
    Semin Ophthalmol; 2008; 23(4):229-34. PubMed ID: 18584560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
    Banerjee K; Biswas PS; Rouse BT
    J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.
    Ferrara N; Hillan KJ; Novotny W
    Biochem Biophys Res Commun; 2005 Jul; 333(2):328-35. PubMed ID: 15961063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of xiaoxingzhang guttae ophthalmic eye drops in the treatment of experimental herpes simplex keratitis].
    Zhang JM; Lin PF; Chen LL; Tang LH; Hong XQ; Liang BX; Chen HS; Teng L
    Zhongguo Zhong Yao Za Zhi; 1993 Jan; 18(1):49-52, 64. PubMed ID: 8391822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents.
    Hosseini H; Nejabat M
    Med Hypotheses; 2007; 68(4):799-801. PubMed ID: 17107753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection.
    Biswas PS; Banerjee K; Kinchington PR; Rouse BT
    Exp Eye Res; 2006 Jan; 82(1):46-54. PubMed ID: 16009363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization.
    Giménez F; Suryawanshi A; Rouse BT
    Prog Retin Eye Res; 2013 Mar; 33():1-9. PubMed ID: 22892644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological aspects of herpetic stromal keratitis.
    Inoue Y
    Semin Ophthalmol; 2008; 23(4):221-7. PubMed ID: 18584559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab (avastin) in ocular processes other than choroidal neovascularization.
    Barkmeier AJ; Akduman L
    Ocul Immunol Inflamm; 2009; 17(2):109-17. PubMed ID: 19412873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation.
    Lobo AM; Agelidis AM; Shukla D
    Ocul Surf; 2019 Jan; 17(1):40-49. PubMed ID: 30317007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.
    Duan R; Remeijer L; van Dun JM; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):277-84. PubMed ID: 17197544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.
    Heiligenhaus A; Bauer D; Meller D; Steuhl KP; Tseng SC
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1969-74. PubMed ID: 11481259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice.
    Miller JK; Laycock KA; Umphress JA; Hook KK; Stuart PM; Pepose JS
    Cornea; 1996 Sep; 15(5):497-504. PubMed ID: 8862927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects.
    Kim B; Lee S; Suvas S; Rouse BT
    J Immunol; 2005 Jul; 175(1):509-16. PubMed ID: 15972686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mimicry versus bystander activation: herpetic stromal keratitis.
    Wickham S; Carr DJ
    Autoimmunity; 2004 Aug; 37(5):393-7. PubMed ID: 15621563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histological and ultrastructural studies of experimental herpetic keratitis in the rabbit].
    Zheng X; Wu J; Wang H
    Zhonghua Yan Ke Za Zhi; 1997 Jan; 33(1):49-52. PubMed ID: 10437002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.